期刊
BIOTECHNOLOGY JOURNAL
卷 15, 期 10, 页码 -出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/biot.201900319
关键词
biocontainment; biosensing; diagnostic; probiotic; therapeutic
资金
- Office of Naval Research [N00014-17-1-2611]
- National Institutes of Health [1R01AT009741-01]
- National Science Foundation [DGE-1745038]
Engineered microbes are exciting alternatives to current diagnostics and therapeutics. Researchers have developed a wide range of genetic tools and parts to engineer probiotic and commensal microbes. Among these tools and parts, biosensors allow the microbes to sense and record or to sense and respond to chemical and environmental signals in the body, enabling them to report on health conditions of the animal host and/or deliver therapeutics in a controlled manner. This review focuses on how biosensing is applied to engineer smart microbes for in vivo diagnostic, therapeutic, and biocontainment goals. Hurdles that need to be overcome when transitioning from high-throughput in vitro systems to low-throughput in vivo animal models, new technologies that can be implemented to alleviate this experimental gap, and areas where future advancements can be made to maximize the utility of biosensing for medical applications are also discussed. As technologies for engineering microbes continue to be developed, these engineered organisms will be used to address many medical challenges.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据